Institution Information
Reportee Signature Date Report period Total Entries Total Value($)
VHCP MANAGEMENT III LLC 08-13-2019 06-30-2019 17 214,180,000
Institutional Holdings
Issuer Class Position Value Shares Portfolio Percentage (%) Previous Percentage (%) Shares Delta Shares Delta(%)
Milestone Pharmaceuticals Inc COM 1 $56,106,000 2,066,529 26.20 2,066,529 +Inf
Axsome Therapeutics Inc COM 2 $41,492,000 1,611,329 19.37 8.86 543,285 50.87
Ra Pharmaceuticals COM 3 $20,157,000 670,350 9.41 7.77 75,637 12.72
Kalvista Pharmaceuticals COM 4 $14,129,000 637,884 6.60 16.19 -332,746 -34.28
Obseva SA COM 5 $13,117,000 1,159,789 6.12 8.65 0 0.00
Protagonist Therapeutics Inc COM 6 $12,986,000 1,072,348 6.06 5.93 263,025 32.50
La Jolla Pharmaceuticals COM 7 $11,580,000 1,251,898 5.41 3.76 248,298 24.74
Tricida Inc COM 8 $11,433,000 289,746 5.34 14.65 -360,839 -55.46
BioCryst Pharmaceuticals Inc COM 9 $10,264,000 2,708,207 4.79 14.53 -352,884 -11.53
Orchard RX Ltd COM 10 $9,461,000 676,252 4.42 8.45 -134,778 -16.62
Marinus Pharmaceuticals Inc COM 11 $5,225,000 1,258,964 2.44 3.07 0 0.00
Kiniksa Pharmaceuticals Ltd COM 12 $4,229,000 312,320 1.97 3.45 -15,457 -4.72
DBV Technologies COM Liquidated $0 0 2.97 636,800 +Inf
Bellerophon Therapeutics COM 14 $1,450,000 2,417,227 0.68 0.92 0 0.00
Kadmon Holdings Inc. COM 15 $870,000 422,141 0.41 2.14 -965,733 -69.58
Constellation Pharmaceuticals COM 16 $819,000 66,667 0.38 0.53 0 0.00
Gemphire Therapeutics COM 17 $646,000 798,066 0.30 0.58 -71,472 -8.22
Proteostasis Therapeutics Inc COM 18 $216,000 221,267 0.10 0.53 -501,623 -69.39
Debug Info- Version: 1.9